Contemporary Concepts in the Treatment of Chronic Osteomyelitis

Oral and Maxillofacial Surgery Clinics of North America

Volumn 19, Issue 4, 2007, Pages 523-534

  Coviello, Vincent ^a   Stevens, Mark R ^b  

^a The Medical College of Georgia ^*  (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CHRONIC DISEASE; DEBRIDEMENT; DIAGNOSTIC IMAGING; HUMAN; HYPERBARIC OXYGEN; JAW DISEASE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; OSTEOMYELITIS; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEBRIDEMENT; DIAGNOSTIC IMAGING; HUMANS; HYPERBARIC OXYGENATION; JAW DISEASES; OSTEOMYELITIS;

EID: 35348850713     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2007.07.001     Document Type: Review

References (70)

1. Cierny G., Mader J.T., and Pennick J.J. A clinical staging system for adult osteomyelitis. Contemp Orthop 10 (1985) 17-37
2. Lew D.P., and Waldvogel F.A. Osteomyelitis. N Engl J Med 336 (1997) 999-1007
3. Craigen M.A., Watters J., and Hackett J.S. The changing epidemiology of osteomyelitis in children. J Bone Joint Surg Br 74 (1992) 541-545
4. Waldvogel F.A., Medhoff G., and Swartz M.N. Osteomyelitis: a review of the clinical features, therapeutic consideration, and unusual aspect. N Engl J Med 282 (1970) 260-266
5. Asensi V., Valle E., Meana A., et al. In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infect Immun 72 7 (2004) 3823-3828
6. Garcia-Alvarez F., Monzon M., Grasa J.M., et al. Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis. J Orthop Sci 11 (2006) 370-374
7. Marx R.E. Chronic osteomyelitis of the jaws. Oral and Maxillofacial Clinics of North America 3 2 (1991) 367-381
8. Calhoun K.H., Shapiro R.D., and Stiernberg C.M. Osteomyelitis of the mandible. Arch Head Neck Surg 114 (1988) 1157
9. Mader J.T., Shirtliff M.E., Bergquist S.C., et al. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res 360 (1999) 47-65
10. Mercuri L.G. Acute osteomyelitis of the jaws. Oral and Maxillofacial Clinics of North America 3 2 (1991) 355-365
11. Marx R.E., Carlson E.R., Smith B.R., et al. Isolation of Actinomyces species and Eikenella corrodens from patients with chronic diffuse sclerosing osteomyelitis. J Oral Maxillofac Surg 52 (1994) 26-33
12. Zuluaga A.F., Galvis W., Saldarriaga J.G., et al. Etiologic diagnosis of chronic osteomyelitis: a prospective study. Arch Intern Med 166 1 (2006) 95-100
13. Storoe W., Haug R.H., and Lillich T.T. The changing face of odontogenic infections. J Oral Maxillofac Surg 59 (2001) 739-748
14. Koorbusch G.F., Fotos P., and Goll K.T. Retrospective assessment of osteomyelitis. Oral Surg Oral Med Oral Pathol 74 (1992) 149-154
15. Scolozzi P., Lombardi T., Edney T., et al. Enteric bacteria mandibular osteomyelitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) E42-E46
16. Robinson J.L., Vaudry W.L., and Dobrovolsky W. Actinomycosis presenting as osteomyelitis in the pediatric population. Pediatr Infect Dis J 24 (2005) 365-369
17. Imamura M., Kakihara T., Yamamoto K., et al. Primary tuberculosis osteomyelitis of the mandible. Pediatr Int 46 (2004) 736-739
18. Bonomo R.A., and Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 43 (2006) S49-S56
19. Howden B.P., Ward P.B., Charles P., et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38 (2004) 521-528
20. Livermore D.M. Interplay of impermeability and chromosomal B-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 36 (1992) 2046-2048
21. Deplano A., Denis O., and Poirel L. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 43 (2005) 1198-1204
22. th edition. 2002. p. 215, 218.
23. Wannfors K., and Gazalius B. Blood flow in jaw bones affected by chronic osteomyelitis. Br J Oral Maxillofac Surg 29 3 (1991) 147-153
24. Dirschl D.R., and Almekinders L.C. Osteomyelitis. Drugs 45 (1993) 29-43
25. Piattelli A., Cosci F., Scarano A., et al. Localized chronic suppurative bone infection as a sequel of peri-implantitis in a hydroxyapatite-coated dental implant. Biomaterials 16 (1995) 917-920
26. Votey SR. Diabetes mellitus, type 2: a review. Emedicine 2005.
27. Aken'Ova Y.A., Bakare R.A., Okunade M.A., et al. Bacterial causes of acute osteomyelitis in sickle cell anaemia: changing infection profile. West Afr J Med 14 4 (1995) 255-258
28. Reinert S., Widlitzek H., and Venderink D.J. The value of magnetic resonance imaging in the diagnosis of mandibular osteomyelitis. Br J Oral Maxillofac Surg 37 (1999) 459-463
29. Rohlin M. Diagnostic value of bone scintigraphy in osteomyelitis of the mandible. Oral Surg Oral Med Oral Path 75 (1993) 650-657
30. Flivik G., Sloth M., Rydholm U., et al. Technetium-99m nanocolloid scintigraphy in orthopedic infections: a comparison with In-111 labeled leukocytes. J Nucl Med 34 (1993) 1646-1650
31. Tumeh S.S., Aliabadi P., Weissman B.N., et al. Disease activity in osteomyeltis: role of radiography. Radiology 165 (1987) 781-784
32. Kaim A.H., Gross T., and von Schulthess G.K. Imaging of chronic posttraumatic osteomyelitis. Eur Radiol 12 (2002) 1193-1202
33. Horger M., Eschmann S.M., Pfannenberg C., et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging 30 12 (2003) 1665-1673
34. Termaat M.F., Raijmakers P.G.H.M., Scholten H.J., et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 87 (2005) 2464-2471
35. Kaim A., Ledermann H.P., Bongartz G., et al. Chronic posttraumatic osteomyelitis of the lower extremity: comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabel led monoclonal antigranulocyte antibodies. Skeletal Radiol 29 (2000) 378-386
36. Senneville E., Legout L., Valette M., et al. Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther 28 8 (2006) 1155-1163
37. De Winter F., Van de Wiele C., Vogelaers D., et al. Flourine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83 5 (2001) 651-660
38. Prandini N., Lazzeri E., Rossi B., et al. Nuclear medicine imaging of bone infections. Nucl Med Commun 27 (2006) 633-644
39. Zhuang H.M., Loman J.C., Cortes-Blanco A., et al. Hyperglycemia does not adversely affect FDG uptake by inflammatory and infectious lesions in FDG-PET imaging. J Nucl Med Suppl 321 (2000)
40. Hakim S.G., Breuker C.W.R., Jacobsen H.C., et al. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int J Oral Maxillofac Surg 35 (2006) 809-816
41. Ludwig Von H., and Haneke A. Ein neues verfahren in der behandlung der osteomyelitis. Dtsch Z Mund-Kiefer-Gesichts-Chir 2 (1978) 190-192
42. Alpert B., Colosi T., von Fraunhofer J.A., et al. The in vivo behavior of gentamicin-PMMA beads in the maxillofacial region. J Oral Maxillofac Surg 47 (1989) 46-49
43. Mendel V., Simanowski H.J., Scholz H.C., et al. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch Orthop Trauma Surg 125 (2005) 363-368
44. Borzsei L., Mintal T., Koos Z., et al. Examination of a novel, specified antibiotic therapy through polymethylmethacrylate capsules in a rabbit osteomyelitits model. Chemotherapy 52 (2006) 73-79
45. Bunetel L., Segui A., Cormier M., et al. Release of gentamycin from acrylic base cement. Clin Pharmacokinet 17 (1989) 271-297
46. von Eiff C., Bettin D., Proctor R.A., et al. Recovery of small colony variants of Staphylococcus aureus following gentamycin bead placement for osteomyelitis. Clin Infect Dis 25 (1997) 1250-1251
47. Garvin K., and Feschuk C. Polylactide-polyglycolide antibiotic implants. Clin Orthop Relat Res 437 (2005) 105-110
48. Joosten U., Joist A., Frebel T., et al. Evaluation of an in situ setting injectible calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials 25 (2004) 4287-4295
49. Joosten U., Joist A., Gosheger G., et al. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials 26 (2005) 5251-5258
50. Kanellakopoulou K., Tsaganos T., Athanassiou K., et al. Comparative elution of moxifloxacin from norian skeletal repair system and acrylic bone cement: an in vitro study. Biomaterials 28 (2006) 217-220
51. Betriu C., Gomez M., Palau M.L., et al. Activities of new antimicrobial agents against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob Agents Chemother 43 9 (1999) 2320-2322
52. Malincarne L., Ghebregzabner M., Moretti M.V., et al. Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty. J Antimicrob Chemother 57 5 (2006) 950-954
53. Gitelis S., and Brebach G.T. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg 10 (2002) 53-60
54. Wang G., Liu S., Ueng S.W., et al. The release of cefazolin and gentamycin from biodegradable PLA/PGA beads. Int J Pharm 273 (2004) 203-212
55. Abazinge M., Jackson T., Yang Q., et al. Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres. Drug Deliv 7 (2000) 77-81
56. Virto M.R., Elorza B., Torrado S., et al. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. Biomaterials 28 (2007) 877-885
57. Koort J.K., Suokas E., Veiranto M., et al. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res A 10 (2006) 532-540
58. Huddleston P.M., Steckelberg J.M., Hanssen A.D., et al. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 82 (2000) 161-173
59. Korkusuz F., Korkusuz P., Eksioglu F., et al. In vivo response to biodegradable controlled antibiotic release systems. J Biomed Mater Res 55 2 (2001) 217-228
60. Mader J.T., Adams K.R., Wallace W.R., et al. Hyperbaric oxygen as adjunctive therapy for osteomyelitis. Infect Dis Clin North Am 4 3 (1990) 433-440
61. Wang C., Schwaitzberg S., Berliner E., et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 138 (2003) 272-279
62. Esterhai J.L., Pisarello J., Brighton C.T., et al. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis. J Trauma 27 7 (1987) 763-768
63. Davis J.C., Hechman J.D., DcLee J.C., et al. Chronic nonhematogenous osteomyelitis treated with adjunct hyperbaric oxygen. J Bone Joint Surg Am 68 (1986) 1210-1217
64. Mader J.T., Guckian J.C., Glass D.L., et al. Therapy with hyperbaric oxygen for the experimental osteomyelitis due to Staphylococcus aureus in rabbits. J Infect Dis 138 3 (1978) 312-318
65. Van Merkesteyn J.P., Bakker D.J., Van der Waal I., et al. Hyperbaric oxygen treatment of chronic osteomyelitis of the jaws. Int J Oral Surg 13 5 (1984) 386-395
66. Harwood P.J., Talbot C., Dimoutsos M., et al. Early experience with linezolid for infections in orthopedics. Injury Int J Care Injured 37 (2006) 818-826
67. Shuford J.A., and Steckelberg J.M. Role of oral antimicrobial therapy in the management of osteomyelitis. Curr Opin Infect Dis 16 (2003) 515-519
68. Rose W., and Rybak M.J. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy 26 8 (2006) 1099-1110
69. Yin L.Y., Lazzarini L., Li F., et al. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 55 (2005) 995-1002
70. Saccidanand S., Penn R.L., and Embil J.M. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections. Int J Infect Dis 9 (2005) 251-261